GL1X · GenesisL1 explorer

MolNFT v1 · #147532 · protein

Crystal structure of human brm in complex with compound 16

6EG2 · MALTOSE/MALTODEXTRIN-binding periplasmic PROTEIN,PROBABLE…: “Crystal structure of human brm in complex with compound 16”. X-ray diffraction, 1 ligand (J7J), 5 pockets (best druggability 0.75). MolNFT v1 #147532 on GenesisL1: 3D…

PDB
6EG2
Type
protein
Length
619 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
MALTOSE/MALTODEXTRIN-binding periplasmic PROTEIN,PROBABLE global transcription activator…
EC
3.6.4.-
UniProt
P0AEY0, P51531
Ligands
J7J
Pockets
5 · best druggability 0.75

Structure

x-ray diffraction · 1 distinct chain · 46% helix, 14% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AMALTOSE/MALTODEXTRIN-binding periplasmic PROTEIN,PROBABLE global transcription activator SNF2L2 (EC 3.6.4.-)protein61946% helix, 14% strandP0AEY0, P51531

Ligands and binding sites

  • J7J · N-(5-amino-2-chloropyridin-4-yl)-N'-(4-bromo-3-{[3-(hydroxymethyl)phenyl]ethynyl}-1,2-thiazol-5-yl)urea · ligand · chains A
  • IPA · Isopropyl alcohol · additive · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13670.750.8542J7J
21840.570.8031empty
32730.560.7731empty
42230.430.7228empty
5560.310.7613empty

Compared structures

  • 6EG2 · Crystal structure of human BRM in complex with compound 16 · the same entry in another collection · chain A against A, TM-score 1.00
  • P51531 · AlphaFold monomer V2.0 prediction for probable global transcription activator SNF2L2… · a predicted model of the same protein · chain A against A, TM-score 0.41

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.